About the Company
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland.
Sector
Industrial Applications and Services
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Employees
14000
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $EW News
Barclays Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
In a report released today, Matt Miksic from Barclays maintained a Buy rating on Edwards Lifesciences (EW – Research Report), with a ...
Edwards gets Q1 boost as Pascal valve repair sales ramp up
New mitral and tricuspid valve treatments are attracting strong demand, but analysts said transcatheter aortic valve replacement sales were shy of expectations.
Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.02, revenue of $1.6B beats by $30M
Edwards Lifesciences reports strong Q1 results, with non-GAAP EPS beating estimates by $0.02 and revenue exceeding expectations by $30M.
Strong Q1 Performance and Positive Market Trends Reinforce Buy Rating for Edwards Lifesciences
Matthew Taylor, an analyst from Jefferies, maintained the Buy rating on Edwards Lifesciences (EW – Research Report). The associated price ...
Edwards Lifesciences Reports First Quarter Results
IRVINE, Calif., April 25, 2024 -- ( BUSINESS WIRE )--Edwards Lifesciences (NYSE: EW) today reported financial results for the ...
This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss
Edwards Lifesciences stock underperformed its peers on Friday, sliding on light sales of its transcatheter aortic heart-valve ...
HCA Healthcare (HCA) Q1 2024 Earnings Call Transcript
Welcome to the HCA Healthcare first quarter 2024 earnings conference call. Today's call is being recorded. At this time, for ...
Loading the latest forecasts...